Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

December 2025

Whole food diet induces remission in children and young adults with mild to moderate Crohn's disease and is more tolerable than exclusive enteral nutrition: A randomized controlled trial

Gastroenterology 2025;169:1462–74 Doi: 10.1053/j.gastro.2025.06.011

Focht G,

Assa A,

Yogev D,

Orlanski-Meyer E,

Broide E,

Kierkuś J,

Kang B,

Weiss B,

Aloi M,

Aharoni-Frutkoff et al. demonstrated that tasty & healthy (T&H) ‘diet’ showed better tolerability than exclusive enteral nutrition (EEN) for inducing remission in mild to moderate CD, while positively affecting the microbiome. Authors explored the tolerability and effectiveness of the T&H diet compared with EEN in children and young adults with mild to moderate uncomplicated CD.

Keywords:

May 2018

Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity Predicts a Low Probability of Achieving Low Disease Activity at Month 6

Arthritis Care Res (Hoboken) 2019 Jan;71(1):71-79. DOI: 10.1002/acr.23585

Lee EB,

This post-hoc analysis of two, Phase 3 studies, ORAL Start and ORAL Standard shows that early treatment response can predict long-term disease activity outcomes. EULAR recommendations suggest that treat-to-target strategies require regular target assessments with treatment approaches changed if targets are not reached at 6 months. To optimize this strategy, therapy outcomes should be known, and the relationship between short and long-term outcomes defined. The current analysis focused on the dis...